Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Takara Bio Inc. ( (JP:4974) ) is now available.
Takara Bio Inc. announced corrections to its financial results forecasts for the fiscal year ending March 31, 2026. The revised forecasts show a significant decrease in net sales and profits, indicating a challenging financial outlook for the company. This adjustment may impact the company’s market positioning and stakeholder confidence.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen931.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc. operates in the biotechnology industry, focusing on developing and providing genetic engineering and molecular biology products and services. The company is headquartered in Kusatsu, Shiga, Japan, and is known for its contributions to life sciences research and development.
Average Trading Volume: 400,591
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen109.9B
Find detailed analytics on 4974 stock on TipRanks’ Stock Analysis page.